Literature DB >> 18049430

Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat.

Palla Suryanarayana1, Alleboena Satyanarayana, Nagalla Balakrishna, Putcha Uday Kumar, Geereddy Bhanuprakash Reddy.   

Abstract

BACKGROUND: There is increasing evidence that complications related to diabetes are associated with increased oxidative stress. Curcumin, an active principle of turmeric, has several biological properties, including antioxidant activity. The protective effect of curcumin and turmeric on streptozotocin (STZ)-induced oxidative stress in various tissues of rats was studied. MATERIAL/
METHODS: Three-month-old Wistar-NIN rats were made diabetic by injecting STZ (35 mg/kg body weight) intraperitoneally and fed either only the AIN-93 diet or the AIN-93 diet containing 0.002% or 0.01% curcumin or 0.5% turmeric for a period of eight weeks. After eight weeks the levels of oxidative stress parameters and activity of antioxidant enzymes were determined in various tissues.
RESULTS: STZ-induced hyperglycemia resulted in increased lipid peroxidation and protein carbonyls in red blood cells and other tissues and altered antioxidant enzyme activities. Interestingly, feeding curcumin and turmeric to the diabetic rats controlled oxidative stress by inhibiting the increase in TBARS and protein carbonyls and reversing altered antioxidant enzyme activities without altering the hyperglycemic state in most of the tissues.
CONCLUSIONS: Turmeric and curcumin appear to be beneficial in preventing diabetes-induced oxidative stress in rats despite unaltered hyperglycemic status.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049430

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  28 in total

1.  Evaluation of Effect of Nishamalaki on STZ and HFHF Diet Induced Diabetic Neuropathy in Wistar Rats.

Authors:  Jayshree Shriram Dawane; Vijaya Anil Pandit; Madhura Shirish Kumar Bhosale; Pallawi Shashank Khatavkar
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 2.  Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.

Authors:  Bharat B Aggarwal
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

3.  Effects of curcumin and γ-oryzanol solid dispersion on the brain of middle-aged rats.

Authors:  Thanyaphon Phothi; Sakara Tunsophon; Waree Tiyaboonchai; Onrawee Khongsombat
Journal:  Biomed Rep       Date:  2022-05-26

Review 4.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

5.  Preventive and Protective Effect of Nishamalaki in STZ Induced Diabetic Complications in Wistar Rats.

Authors:  Jayshree Shriram Dawane; Vijaya Anil Pandit; Swapnil Suryakant Deshpande; Amruta Sumedh Mandpe
Journal:  J Clin Diagn Res       Date:  2016-06-01

6.  Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review.

Authors:  Zeinab Nazarian-Samani; Robert D E Sewell; Zahra Lorigooini; Mahmoud Rafieian-Kopaei
Journal:  Curr Diab Rep       Date:  2018-08-13       Impact factor: 4.810

Review 7.  Antioxidant Phytochemicals for the Prevention of Fluoride-Induced Oxidative Stress and Apoptosis: a Review.

Authors:  Linet M Angwa; Yuting Jiang; Junrui Pei; Dianjun Sun
Journal:  Biol Trace Elem Res       Date:  2021-05-18       Impact factor: 3.738

8.  Effect of novel water soluble curcumin derivative on experimental type- 1 diabetes mellitus (short term study).

Authors:  Mohamed T Abdel Aziz; Mohamed F El-Asmar; Ibrahim N El-Ibrashy; Ameen M Rezq; Abdulrahman L Al-Malki; Mohamed A Wassef; Hanan H Fouad; Hanan H Ahmed; Fatma M Taha; Amira A Hassouna; Heba M Morsi
Journal:  Diabetol Metab Syndr       Date:  2012-07-04       Impact factor: 3.320

Review 9.  Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress.

Authors:  Alba Naudi; Mariona Jove; Victoria Ayala; Anna Cassanye; Jose Serrano; Hugo Gonzalo; Jordi Boada; Joan Prat; Manuel Portero-Otin; Reinald Pamplona
Journal:  Exp Diabetes Res       Date:  2012-01-02

Review 10.  Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.